BTK and Multiple Organ Failure: Most notably, ibrutinib significantly reduced sepsis-induced multiple organ failure in WT-mice but had no further beneficial effect in Xid-mice subjected to CLP-indicating that the observed beneficial effect of ibrutinib in WT-mice can solely be explained by inhibition of BTK-activity.